Karyopharm Therapeutics (KPTI) Interest & Investment Income (2013 - 2026)
Karyopharm Therapeutics (KPTI) reported Interest & Investment Income of $722,000 for Q2 2026, up 17.8% from $613,000 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Interest & Investment Income (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Karyopharm Therapeutics' Interest & Investment Income came in at $2.5 million, down 49.4% year-over-year; for FY2025, it came in at $2.77 million, down 62.5% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $7.4 million in FY2024 (-32.4%), $10.94 million in FY2023 (+363.9%), $2.36 million in FY2022 (+305.3%) and $582,000 in FY2021 (-79.4%).
- The Q2 2026 figure ranks as the highest quarterly Interest & Investment Income since Q1 2025.
- Year over year, Interest & Investment Income gained in 1 of the last seven quarters, with an average decline of 43.9%.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2023 (growth of 863.8%); the low point was Q4 2021 (a decline of 86.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Karyopharm Therapeutics | 23.15 Mn | -203.27 Mn | 32.35 Mn | 722,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 722,000.00 |
| Dec 31, 2025 | 607,000.00 |
| Sep 30, 2025 | 553,000.00 |
| Jun 30, 2025 | 613,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 2.52 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 658,000.00 |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 98,000.00 |
| Jun 30, 2021 | 165,000.00 |
API Access
Karyopharm Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();